Results 101 to 110 of about 50,234 (263)

Machine learning methods for predicting adverse drug events: A systematic review

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 422-444, February 2026.
Abstract Predicting adverse drug events (ADEs) in outpatient settings is crucial for improving medication safety, identifying high‐risk patients and reducing health‐care costs. While traditional methods struggle with the complexity of health‐care data, machine learning (ML) models offer improved prediction capabilities; however, their effectiveness in ...
Niaz Chalabianloo   +8 more
wiley   +1 more source

Omeprazole inhibits colorectal carcinogenesis induced by azoxymethane in rats. [PDF]

open access: bronze, 1993
Ian Penman   +5 more
openalex   +1 more source

Strategy for Identifying Rational Sensitivity Analysis Using PBPK Modeling for Precipitant Drug–Drug Interaction Predictions

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 2, Page 314-317, February 2026.
Physiology Based Pharmacokinetic (PBPK) modeling is an established essential tool for predicting and/or analyzing drug–drug interactions (DDI). Uncertainty and variability associated with in vitro determined DDI‐related parameters have often been considered a limitation for predicting PBPK‐DDIs.
Kunal S. Taskar   +2 more
wiley   +1 more source

Comparative Effectiveness of Omeprazole and Lansoprazole in Gastroesophageal Reflux Disease (GERD): A Review Article

open access: yesJournal of Nepal Medical Association
This review discusses the use of Omeprazole and Lansoprazole as therapy in patients with Gastroesophageal Reflux Disease (GERD). GERD is a digestive tract disorder caused by repeated reflux of stomach contents into the esophagus.
Rizky Gustinanda   +3 more
doaj   +1 more source

Omeprazole Inhibits Glioblastoma Cell Invasion and Tumor Growth [PDF]

open access: gold, 2020
Un-Ho Jin   +5 more
openalex   +1 more source

Gut Microbial Variations Associated With Proton Pump Inhibitor Use in the Boston Puerto Rican Health Study

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT Proton pump inhibitors (PPI), used to treat gastrointestinal disorders, are associated with alterations in the gut microbiome. However, this is understudied in Puerto Ricans who have unique lifestyle characteristics. Puerto Ricans, including participants of the Boston‐Puerto Rican Health Study (BPRHS), report high PPI use.
Deepika Dinesh   +10 more
wiley   +1 more source

Staphylococcus aureus pneumonia and pararectal abscess in a horse secondary to catheter‐related septic thrombophlebitis

open access: yesVeterinary Record Case Reports, Volume 14, Issue 1, February 2026.
Abstract This report describes the development of methicillin‐sensitive Staphylococcus aureus septic jugular thrombophlebitis, pneumonia and a delayed‐onset pararectal abscess secondary to bacterial embolization from intravenous catheterization in a horse and demonstrates the successful treatment of all aspects. A racing Arabian mare was presented with
Tiago Fernandes, Camilla A. Jamieson
wiley   +1 more source

Assessment of toxicity and oxidative stress associated with omeprazole in Caenorhabditis elegans

open access: yesActa Scientiarum: Biological Sciences
Omeprazole is an inhibitor of the proton pump which has been extensively studied presently due to the evidence of a potential toxicity related to the generation of reactive species of oxygen (ROS) to its chronic users.
Gabriela Endres da Rocha Pompeo   +4 more
doaj   +1 more source

H. PYLORI STATUS INFLUENCES THE EFFICACY OF OMEPRAZOLE 20MG BUT NOT RANITIDINE 75MG FOR PREVENTION OF NIGHTTIME HEARTBURN FOLLOWING A PROVOCATIVE MEAL [PDF]

open access: bronze, 2003
Michael G. Donnelly   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy